Bis-(m-PEG4)-amidohexanoic acid

 CAS No.: 2353409-74-0  Cat No.: BP-500356 4.5  

Bis-(m-PEG4)-amidohexanoic acid is a lysine-derived, mPEG-substituted monoacid linker. Structurally, it contains a central hexanoic acid framework bearing two amide-linked methoxy-PEG4 substituents and one free carboxylic acid. The methoxy PEG termini are capped and nonreactive, whereas the central carboxylic acid can be activated for amide coupling with an amine-bearing ligand or converted into an ester with an alcohol. In PROTAC and related targeted protein degradation research, the two mPEG arms can increase polarity and steric shielding while the single acid provides the defined covalent attachment site. Its defined architecture allows researchers to evaluate how linker polarity, flexibility, attachment sequence, and terminal-group selection influence conjugate preparation and the spatial requirements of productive target–E3 ligase engagement. Clear assignment of the protected and reactive groups also supports reproducible reaction planning and systematic comparison of alternative linker designs in research-focused targeted protein degradation workflows.

Bis-(m-PEG4)-amidohexanoic acid

Structure of 2353409-74-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC Linker
Molecular Formula
C₂₆H₅₀N₂O₁₂
Molecular Weight
582.68

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping
Room temperature in continental US; may vary elsewhere.
IUPACName
(2R)-2,6-bis[3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]propanoylamino]hexanoic acid
InChI Key
VEMVVACPIWNZPA-HSZRJFAPSA-N
InChI
InChI=1S/C26H50N2O12/c1-33-11-13-37-19-21-39-17-15-35-9-6-24(29)27-8-4-3-5-23(26(31)32)28-25(30)7-10-36-16-18-40-22-20-38-14-12-34-2/h23H,3-22H2,1-2H3,(H,27,29)(H,28,30)(H,31,32)/t23-/m1/s1
SMILES
COCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)CCOCCOCCOCCOC
1. Boroxine template for macrocyclization and postfunctionalization
Kosuke Ono, Satoru Onodera, Hidetoshi Kawai Chem Commun (Camb). 2022 Nov 10;58(90):12544-12547.doi: 10.1039/d2cc04691a.
A novel synthetic strategy for large macrocyclic molecules using boroxine formation was developed. For this, the threefold intramolecular olefin metathesis of 3,5-bis(alkenyloxy)phenylboroxines with various lengths of alkenyl chains, formed by the dehydration of the corresponding boronic acid substrates, together with treatment with pinacol, was used to produce 39-, 45-, and 51-membered macrocyclic compounds with three boronate units. The boroxine moiety functions as a covalent template but can also be used to postmodify the macrocycle. Boroxine-templated macrocyclization implemented in this way does not require the addition of template molecules and simplifies the synthetic procedure.
2. Bis-Boronic Acid Liposomes for Carbohydrate Recognition and Cellular Delivery
Megan L Qualls, Hannah Hagewood, Jinchao Lou, Samuel I Mattern-Schain, Xiaoyu Zhang, Deidra J Mountain, Michael D Best Chembiochem. 2022 Nov 4;23(21):e202200402.doi: 10.1002/cbic.202200402.Epub 2022 Sep 21.
Liposomes are effective therapeutic nanocarriers due to their ability to encapsulate and enhance the pharmacokinetic properties of a wide range of drugs and diagnostic agents. A primary area in which improvement is needed for liposomal drug delivery is to maximize the delivery of these nanocarriers to cells. Cell membrane glycans provide exciting targets for liposomal delivery since they are often densely clustered on cell membranes and glycan overabundance and aberrant glycosylation patterns are a common feature of diseased cells. Herein, we report a liposome platform incorporating bis-boronic acid lipids (BBALs) to increase valency in order to achieve selective saccharide sensing and enhance cell surface recognition based on carbohydrate binding interactions. In order to vary properties, multiple BBALs (1 a-d) with variable linkers in between the binding units were designed and synthesized. Fluorescence-based microplate screening of carbohydrate binding showed that these compounds exhibit varying binding properties depending on their structures. Additionally, fluorescence microscopy experiments indicated enhancements in cellular association when BBALs were incorporated within liposomes. These results demonstrate that multivalent BBALs serve as an exciting glycan binding liposome system for targeted delivery.
3. Bis-Boric Acid-Mediated Regioselective Reductive Aminolysis of 3,4-Epoxy Alcohols
Wei Tang, Chuan Wang J Org Chem. 2022 Nov 18;87(22):15653-15660.doi: 10.1021/acs.joc.2c01878.Epub 2022 Nov 3.
Herein we report a bis-boric acid-mediated regioselective reductive aminolysis of 3,4-epoxy alcohols, providing new access to prepare amino diols in high diastereofidelity directly starting from nitroarenes. Notably, this step-economical process is enabled by the essential dual function of bis-boric acid, which is engaged initially in the 4,4'-bipyridine-catalyzed reduction of nitro compounds as the reductant and subsequently promotes the ring opening reaction of 3,4-epoxy alcohols with the in situ-generated anilines.

Bis-(m-PEG4)-amidohexanoic acid is a PEG-based linker designed to support flexible, water-compatible conjugation in targeted protein degradation (PROTAC) workflows. Its hydrophilic poly(ethylene glycol) character can help tune linker solubility and conformational freedom between a ligand and an E3-recruiting module, supporting productive ternary complex formation. The structure and reactivity considerations for constructing PROTACs using this linker are described in detail below.

Structure: This linker contains a central amide-bearing hexanoic acid framework connected to bis–m-PEG4 substituents. It features multiple ether linkages characteristic of PEG segments, plus amide and carboxylic acid functional groups. The resulting architecture provides pronounced hydrophilicity, conformational flexibility, and stable covalent attachment points for PROTAC assembly.

Reactivity: The carboxylic acid and amide functionalities enable standard peptide-coupling strategies to form PROTAC conjugates, typically via activation of the acid followed by nucleophilic substitution with an appropriately functionalized ligand. Common approaches employ carbodiimide or uronium-type coupling reagents in compatible polar solvents under controlled pH to minimize PEG degradation. Reaction conditions should preserve ester/ether integrity and maintain linker solubility for reproducible coupling efficiency.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket